SI3731817T1 - Farmacevtski sestavek farmacevtsko sprejemljive adicijske soli lenalidomida s kislino - Google Patents
Farmacevtski sestavek farmacevtsko sprejemljive adicijske soli lenalidomida s kislinoInfo
- Publication number
- SI3731817T1 SI3731817T1 SI201831228T SI201831228T SI3731817T1 SI 3731817 T1 SI3731817 T1 SI 3731817T1 SI 201831228 T SI201831228 T SI 201831228T SI 201831228 T SI201831228 T SI 201831228T SI 3731817 T1 SI3731817 T1 SI 3731817T1
- Authority
- SI
- Slovenia
- Prior art keywords
- lenalidomide
- pharmaceutically acceptable
- pharmaceutical composition
- acid addition
- addition salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17210683.3A EP3505158A1 (en) | 2017-12-27 | 2017-12-27 | Pharmaceutical composition of lenalidomide pharmaceutically acceptable acid addition salt |
| EP18826728.0A EP3731817B1 (en) | 2017-12-27 | 2018-12-21 | Pharmaceutical composition of lenalidomide pharmaceutically acceptable acid addition salt |
| PCT/EP2018/086675 WO2019129726A1 (en) | 2017-12-27 | 2018-12-21 | Pharmaceutical composition of lenalidomide pharmaceutically acceptable acid addition salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3731817T1 true SI3731817T1 (sl) | 2025-06-30 |
Family
ID=60990593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201831228T SI3731817T1 (sl) | 2017-12-27 | 2018-12-21 | Farmacevtski sestavek farmacevtsko sprejemljive adicijske soli lenalidomida s kislino |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP3505158A1 (sl) |
| EA (1) | EA202091561A1 (sl) |
| SI (1) | SI3731817T1 (sl) |
| WO (1) | WO2019129726A1 (sl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7420529B2 (ja) * | 2019-10-31 | 2024-01-23 | 東和薬品株式会社 | レナリドミドを含む医薬組成物 |
| EP4233849A1 (en) * | 2022-02-25 | 2023-08-30 | KRKA, d.d., Novo mesto | Pharmaceutical composition comprising pomalidomide |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69717831T3 (de) | 1996-07-24 | 2018-08-30 | Celgene Corp. | Substituierte 2-(2,6-dioxopiperidin-3-yl)-phthalimide und -1-oxoisoindoline und verfahren zur reduzierung des tnf-alpha-spiegels |
| UA83504C2 (en) | 2003-09-04 | 2008-07-25 | Селджин Корпорейшн | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| CA2717326C (en) | 2008-03-11 | 2018-10-23 | Dr. Reddy's Laboratories Ltd. | Preparation of lenalidomide |
| US20110060010A1 (en) | 2008-03-13 | 2011-03-10 | Tianjin Hemay Bio-Tech Co., Ltd | Salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione and derivatives thereof, or polymorphs of salts, process for preparing same and use thereof |
| EP2355802A1 (de) | 2008-11-14 | 2011-08-17 | Ratiopharm GmbH | Intermediate und orale darreichungsformen enthaltend lenalidomid |
| EP2464638A1 (en) | 2009-08-12 | 2012-06-20 | Synthon B.V. | Lenalidomide salts |
| WO2011050962A1 (en) | 2009-10-29 | 2011-05-05 | Ratiopharm Gmbh | Acid addition salts of lenalidomide |
| CA2842316A1 (en) | 2011-07-19 | 2013-01-24 | Amplio Pharma, Llc | Urea cocrystal of 3-(4-amin0-1-0x0-1,3 dihydro-isoindol-2-yl)piperidine-2,6-dione |
| WO2014160686A1 (en) | 2013-03-26 | 2014-10-02 | Celgene Corporation | Solid forms comprising 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof |
| EP3744318A1 (en) * | 2015-08-27 | 2020-12-02 | Grindeks, A Joint Stock Company | Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications |
-
2017
- 2017-12-27 EP EP17210683.3A patent/EP3505158A1/en not_active Withdrawn
-
2018
- 2018-12-21 EP EP18826728.0A patent/EP3731817B1/en active Active
- 2018-12-21 SI SI201831228T patent/SI3731817T1/sl unknown
- 2018-12-21 EA EA202091561A patent/EA202091561A1/ru unknown
- 2018-12-21 WO PCT/EP2018/086675 patent/WO2019129726A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3731817B1 (en) | 2025-01-22 |
| EP3505158A1 (en) | 2019-07-03 |
| WO2019129726A1 (en) | 2019-07-04 |
| EA202091561A1 (ru) | 2020-11-20 |
| EP3731817A1 (en) | 2020-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279464A (en) | Pharmaceutical formulation of odevixibat | |
| EP3116492A4 (en) | Pharmaceutical compositions of therapeutically active compounds | |
| SMT202100444T1 (it) | Composizioni farmaceutiche di composti terapeuticamente attivi | |
| IL261444A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis | |
| IL271807A (en) | New compounds and their pharmaceutical preparations for the treatment of leprosy | |
| ZA201908454B (en) | Solid preparation of cariprazine for oral administration | |
| IL273451A (en) | Pharmaceutical preparations for administration of peptides | |
| EP3493808A4 (en) | PHARMACEUTICAL COMPOSITIONS OF IBRUTINIB | |
| LT3318259T (lt) | Stabili farmacinė kompozicija, skirta peroraliniam vartojimui | |
| SG10202008700VA (en) | α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| SI3731817T1 (sl) | Farmacevtski sestavek farmacevtsko sprejemljive adicijske soli lenalidomida s kislino | |
| IL267279A (en) | Pharmaceutical formulations of suvorexant | |
| PT3650024T (pt) | Composição farmacêutica para administração nasal compreendendo rifampicinas para tratar demência | |
| KR101583452B9 (ko) | 위장질환 치료용 의약 조성물 | |
| ZA201801839B (en) | Pharmaceutical composition for preventing and treating liver diseases, containing, as active ingredient, cromolyn or pharmaceutically acceptable salt thereof | |
| IL253788A0 (en) | Raccadotril pharmaceutical preparations | |
| ZA201803722B (en) | Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof | |
| GB2569616B (en) | Sustained release oral pharmaceutical compositions of dicycloverine | |
| GB201714241D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| EP3222271A4 (en) | Stable pharmaceutical composition comprising pemetrexed or pharmaceutically acceptable salt thereof | |
| HUP1400519A2 (hu) | Gyógyászati készítmény elõállítására alkalmazható laquinimod kristályforma és laquinimod nátrium só kristályforma |